SNHG10 and Parkinson disease: Since neuroinflammation is a major factor promoting the progression of Parkinson’s disease [28], these data indicate modulating the expression of SNHG10 and miR-1277-5p could potentially ameliorate the neuroinflammatory condition in Parkinson’s disease, which is needed to be further investigated in the animal model of Parkinson’s disease.